HSF1 and Alzheimer disease: Overexpression of C/EBPα or HSF1 in young 3xTg mice did not significantly accelerate the onset of AD-like pathogenesis or worsen cognitive dysfunctions (Fig. 6c–h; Supplementary Fig. 7).